BTTR - Better Choice Acquires Aimia Pet Healthco to Enter the GLP1 Pet Market | Benzinga
NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE:BTTR) ("Better Choice" or "the Company"), a pet health and wellness company, today announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco Inc. (‘Aimia'). Better Choice will now be in a position to manage the clinical trials internally in hopes to develop a supplement to support weight loss in domestic animals.
More than half of all dogs and cats worldwide are classified as overweight or obese and can suffer from the same weight-related health complications as humans – including arthritis, diabetes, and high blood pressure. Following the successful creation by Pfizer of its Slentrol medication, Better Choice will work with Aimia to develop treats and toppers to safely combat pet obesity.
The goal of the research and development work is to mirror the weight loss benefits of leading brands for domestic animals and in humans including Slentrol, Wegovy, Ozempic, and Mounjaro ...